FDA approves first eyelash enhancing drug

December 29, 2008

ChattahBox) — This might not be as revolutionary as Viagra but it’s going to be big. The Food and Drug Administration (FDA) recently approved the first drug meant to to enhance dull or thinning lashes. The new drug Latisse for eyelashes has been created by Allergan, the company behind the anti-wrinkle drug Botox.

The drug was created to treat those who have hypotrichosis, a condition in which a person does not have enough eyelashes. Latisse be available early next year by prescription and a 30-day supply is expected to cost $120, according to reports. The drug is the first prescription product for lengthening eyelashes, making sales forecasting a little difficult although Allergan said it estimates global peak sales could top 500 million U.S. dollars a year.

The active ingredient in the once-daily prescription treatment is bimatroprost, the same ingredient that is in Allergan’s glaucoma treatment Lumigan. It was a glaucoma specialist who first discovered the eyelash effect.

Allergan states that “Latisse users can expect to experience longer, fuller, and darker eyelashes in as little as eight weeks, with full results in 16 weeks.” If Latisse is stopped, eyelashes will gradually return to their previous appearance as new eyelashes grow in.

The company also stated, “Latisse is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.”

Allergan noted that Latisse may cause darkening of the eyelid skin, which may be reversible, and it “may also cause increased brown pigmentation of the colored part of the eye, which is likely to be permanent.”

That last part might be a big deal for those with green or blue eyes in particular.


Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.